| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Revenue | $5.7B (+4.8% organic in Q4) | $5.1B (+2.9% organic in Q1) | Decelerated 190 bps organically |
| Adjusted EBIT Margin | 16.7% (down 200 bps YoY) | 13.5% (down 150 bps YoY) | Compressed 320 bps sequentially |
| Adjusted EPS | $1.44 (down 0.7%) | $0.99 (includes $0.16 tariff) | Down 31% sequentially, 21% excluding tariffs |
| Free Cash Flow | $916M (up $105M) | $112M (up $13M YoY) | Collapsed 88% sequentially |
| Backlog | $21.8B (record, up $2B YoY) | $21.8B (up $1.2B YoY) | Flat sequentially, YoY growth decelerated |
| PDx Organic Growth | 12.7% in Q4 | 9.7% in Q1 | Decelerated 300 bps |
| PCS Organic Growth | -1.1% in Q4 | -8.1% in Q1 | Deteriorated 700 bps |
| PCS EBIT Margin | Improved 530 bps sequentially | Down 500 bps YoY | Major margin volatility signals instability |
| Imaging Organic Growth | 5.3% in Q4 | 3.8% in Q1 | Decelerated 150 bps |
| AVS Organic Growth | 4.2% in Q4 | 4.4% in Q1 | Slight acceleration of 20 bps |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.